Host-Microbiome Interactions in Chronic Itch.

Area of Science:

• Dermatology
• Microbiology
• Neuroimmunology

Background:

• Chronic itch, persisting over six weeks, severely affects patient quality of life.
• The skin microbiome's role in non-atopic chronic itch disorders is not well understood.
• Existing research primarily focuses on the immune system and neural circuits in itch.

Purpose of the Study:

• To review emerging evidence on the skin microbiome's contribution to chronic pruritus.
• To explore the molecular pathways linking microbial dysbiosis to chronic itch.
• To highlight therapeutic strategies targeting the microbiome and neuroinflammation.

Main Methods:

• Literature review synthesizing recent studies on skin microbiome and chronic itch.
• Analysis of molecular pathways involved in microbial dysbiosis and pruritus.
• Evaluation of current and emerging therapeutic interventions.

Main Results:

• Microbial dysbiosis contributes to chronic itch via skin barrier disruption, altered neuroimmune signaling, and direct pruriceptor activation.
• Specific microbiome shifts are observed in prurigo nodularis (PN) and lichen simplex chronicus (LSC), independent of atopic dermatitis (AD).
• Biologics and small molecules show potential in modulating immune responses, restoring microbial balance, and reducing neuroinflammation.

Conclusions:

• The skin microbiome plays a significant role in chronic itch, particularly in non-atopic conditions.
• A systems biology approach integrating genomics, neurobiology, and immunology is essential for understanding host-microbe interactions in chronic itch.
• Targeted therapies modulating immune responses and microbial balance offer promising avenues for treating chronic pruritus.